Hyper-Fractionated Radiotherapy for Soft Tissue Sarcoma: Results of the Second Study of Hyper-Fractionated Radiotherapy

por Jacob, R., Gilligan, D., Robinson, M., Harmer, C.
Publicado 1999

Performance status score: do patients and their oncologists agree?

por Blagden, S P, Charman, S C, Sharples, L D, Magee, L R A, Gilligan, D
Publicado 2003

Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer

por Gale, D., Heider, K., Ruiz-Valdepenas, A., Hackinger, S., Perry, M., Marsico, G., Rundell, V., Wulff, J., Sharma, G., Knock, H., Castedo, J., Cooper, W., Zhao, H., Smith, C.G., Garg, S., Anand, S., Howarth, K., Gilligan, D., Harden, S.V., Rassl, D.M., Rintoul, R.C., Rosenfeld, N.
Publicado 2022

Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma

por Noble, F, Lloyd, M A, Turkington, R, Griffiths, E, O'Donovan, M, O'Neill, J R, Mercer, S, Parsons, S L, Fitzgerald, R C, Underwood, T J, Noorani, A, Fels Elliott, R, Abdullahi, Z, de la Rue, R, Bornschein, J, MacRae, S, Nutzinger, B, Grehan, N, Contino, G, Crawte, J, Edwards, P A W, Miremadi, A, Malhotra, S, Hayden, A, Walker, R, Peters, C, Hannah, G, Hardwick, R, Davies, J, Ford, H, Gilligan, D, Safranek, P, Hindmarsh, A, Sujendran, V, Carroll, N, McManus, D, Hayes, S J, Ang, Y, Preston, S R, Oakes, S, Bagwan, I, Skipworth, R J E, Save, V, Hupp, T R, Puig, S, Bedford, M, Taniere, P, Whiting, J, Byrne, J, Kelly, J, Owsley, J, Crichton, C, Barr, H, Shepherd, N, Old, O, Lagergren, J, Gossage, J, Davies, A, Chang, F, Zylstra, J, Sanders, G, Berrisford, R, Harden, C, Bunting, D, Lewis, M, Cheong, E, Kumar, B, Saunders, J H, Soomro, I N, Vohra, R, Duffy, J, Kaye, P, Grabowska, A, Lovat, L, Haidry, R, Eneh, V, Igali, L, Welch, I, Scott, M, Sothi, S, Suortamo, S, Lishman, S, Beardsmore, D, Sutaria, R, Secrier, M, Eldridge, M D, Bower, L, Lynch, A G, Tavaré, S
Publicado 2017